The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.
Market breadth is positive with 942 advances and 196 declines.
Markets ended their lowest close in 2015 on fears of FII outflows as the US Fed may hike rates.
The US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.
The past eight months have seen vast improvement in the Indian economy, says Edelweiss Group chairman and chief executive Rashesh Shah, who feels domestic-oriented sectors are likely to do better.
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
According to market experts, GST Bill, movement of the rupee and uncertain global cues amid expected rate cut by the US Fed will dictate the movement of the markets.
Investors turn their attention to export-driven sectors.
Companies that are developing biosimilars (for regulated markets) or have portfolio of new chemical entities (NCEs) under development.
With global markets pushing ahead, enthused by strengthening US jobs market, and also due to prospects of European rate hike, Indian markets also continued the march ahead.
Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.
Sun Pharma would have to do a lot of work to get USFDA to revoke the ban on Ranbaxy facilities but it has not put any time-frame for this, company ChairmanIsrael Makov said.
Sensex, Nifty put up a good show in closing trade.
Financials ended mixed despite the status-quo on key rates by the RBI. SBI, ICICI Bank and Axis Bank ended up 0.4-2.5% each.
Benchmark indices finished higher on hopes of economic reforms
Another year of strong performance by these export-oriented sectors likely as US economy revives and rupee is expected to be under pressure.
Move follows a spate of international regulatory enforcements on Indian drug firms.
The higher rate cut by RBI is positive for rate-sensitive sectors in the medium to long term.
Indian equity markets registered their highest single-day percentage gains since early October.
The S&P BSE Sensex closed at 26,190, up by 43 points and Nifty50 settled above 7,950 to end at 7,963, up by 17 points
Gains were led by index heavyweights with Reliance Industries contributing the most.
The S&P BSE Sensex gained 115 points to end at 24,338 and the Nifty50 climbed 42 points to close at 7,404.
'There are different kinds of risk.' 'It is a very powerful value. Your ability to de-risk the risk is also as important for risk taking.'
Stellar rally in ITC shares along with strength in the Asian equities capped the downside.
IT shares lost ground tracking a sell-off in tech stocks on Nasdaq on Friday
Indices reversed all its losses during late trades.
The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.
The challenge of merging Ranbaxy into the company has not been factored in.
Nanotechnology researcher Dr Anita Goel feels that India can benefit from the gene Radar sensing technology which can detect the presence or absence of a disease's pathogen with the same accuracy available only in a diagnostic lab, reports Suman Guha Mozumder.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
The 30-share Sensex ended up 292 points at 29,571 and the 50-share Nifty closed up 75 points at 8,910.
Torrent to buy Ranbaxy's anti-bacterial generic
The Sensex ended below 28,000 for the second straight day at 27,869.
Stockmarket Gurus Raamdeo Agrawal, Manish Gunwani, S Naren and Nilesh Shah discuss their favourite themes for the New Year.
The 30-share Sensex ended 50 points lower at 28,112 and the 50-share Nifty declined 12 points to close at 8,531.
BSE Midcap and Smallcap indices ended in line with their larger counterparts and closed marginally up 0.2% and 0.4%, each
Currently, Himalaya sells 250 products across the globe.
Market breadth continued to remain strong, with 1899 gainers and 674 losers on the BSEs.
'We have created an enemy we can't even see and that enemy is entertaining us while tightening the noose around our necks.' 'As the radiation increases, it will affect everything -- from your little bumble bee to plants to every living cell.' 'By the time the effects are understood, it might be too late.'
Dilip Shanghvi has never tried to be everything to everybody.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances